OneMedNet Corp (ONMD): Entry into a Material Definitive Agreement
OneMedNet Corp (ONMD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 STANDBY EQUITY PURCHASE AGREEMENT THIS STANDBY EQUITY PURCHASE AGREEMENT (this “ Agreement ”) dated as of July 1, 2026 is made by and between YA II PN, LTD. , a Cayman Islands exempt limited company (the “ Investor ”), and ONEMEDNET CORPO
How this was made
The 30-second read
Why it matters
This creates a defined pathway for OneMedNet to raise up to $25M in common stock, subject to ownership limits (4.99%) and an exchange cap (19.99% unless stockholder approval allows more). Market participants typically price such facilities as a potential dilution overhang, especially if the company is likely to draw.
Market read
Traders can update dilution/risk models for ONMD based on the newly disclosed $25M standby equity purchase facility and its caps/constraints.
What to watch
Key terms like minimum acceptable price, pricing mechanics, and whether any advances are actually initiated are not fully shown in the excerpt; those details will determine real dilution timing and magnitude.
Background
The 8-K reports entry into a standby equity purchase agreement (an equity line) between YA II PN, LTD. and OneMedNet, enabling potential share sales “from time to time” during a commitment period.
Ticker impact
OneMedNet entered a material definitive standby equity purchase agreement allowing the company to sell up to $25M of common stock to YA II PN, LTD.
Near-term sentiment may be mildly negative/volatile due to potential dilution, but magnitude depends on whether and how quickly advances are requested and at what prices.
The 8-K is a primary disclosure of a $25M standby equity purchase facility with ownership and exchange caps; it does not state immediate issuance, but it creates a clear future dilution overhang risk.
Market effects
Adds another example of small/mid-cap using standby equity purchase structures, which can influence how traders price dilution risk in similar names.
Primarily US-listed Nasdaq small-cap sentiment; limited broader regional spillover expected.
Low global relevance; financing structure is company-specific with no stated cross-border operational impact.
Counterpoint
If the company has sufficient cash runway and does not request advances, the facility may be viewed as optional liquidity rather than imminent dilution.
Key entities
- issuerOneMedNet Corporation
Nasdaq-listed company (ONMD) entering the standby equity purchase agreement.
- investorYA II PN, LTD.
Cayman Islands exempt limited company that will purchase common shares up to the facility amount.
